Cellino

Big news at @CellinoBio! We’re excited to appoint Ed Tekeian as Chief Operating Officer. Ed will oversee engineering, platform development, & manufacturing as we build the scalable infrastructure needed for personalized #regenerativemedicine. Read the full release: bwnews.pr/4siZbn1

A milestone for regenerative medicine: 20 years after #Japan pioneered induced pluripotent stem cells (#iPSCs), the country has granted the first-ever authorizations to manufacture and sell medical products based on the technology. Story via @WIRED. wired.com/story/japan-ap…

A whole new wave of disease therapies have started to arrive. They're based on lab made stem cells that can reprogram the body. Folks like @JeffBezos, @sama and @brian_armstrong have invested billions of dollars into this technology. @nabsicle is trying to mass produce these new stem cells to make the therapies cheaper and more widespread. This is our full episode with her where we get deep into iPSCs and how this technology works. The @corememory podcast is on all major platforms and on YouTube down below. @brexHQ and @e1ventures are very smart and help us bring the world's smartest podcast to you. Enjoy! Timestamps 00:00 Intro 01:22 Cell Rejuvenation 02:30 AI and Biotech 06:18 Lab-Made vs Natural Stem Cells 08:25 Programming Cell States 10:07 Reversing Parkinson's 12:15 Japan’s Stem Cell Trials 16:46 Personalized Cells 21:19 Cellino’s Laser Bubble Technology 31:34 Stem Cell Fabs 38:33 Personalized Medicine 43:02 Lowering Stem Cell Therapy Costs 46:31 Can Humans Live Forever?

#ICYMI: @nabsicle joined @ashleevance on the @corememory podcast to discuss the rapidly evolving field of #iPSCs and what it could mean for the future of #regenerativehealth. Listen to the full episode: bit.ly/4uHSAUO

Recorded this @corememory episode with @ashleevance before Japan approved the first iPSC-derived therapies on Feb 19, 2026. That timing gives me chills!! 🧠💓 He’s one of my favorite storytellers and did you know he loves iPSCs as much as I do?! This is a conversation I will cherish for a long time. 🙏🏼🚀 thank you for having me! youtu.be/cXdVhpP4V7Q?si…

Now live: Our Co-Founder & CEO, @nabsicle, joins @ashleevance on @corememory to discuss “the race to reboot human cells” and the role of #iPSCs in #regenerativemedicine. Watch it here: youtube.com/watch?v=cXdVhp…

Well, we're doing neuron transplants now, friends. Coming up on the next episode of the @corememory pod with @nabsicle

👏 Big news at @CellinoBio! Our Co-Founder @MadridMarinna has expanded her role to Chief Product & Regulatory Officer and joins the Board of Directors. 📄 Read the full release: businesswire.com/news/home/2026…

🔬 Marking 20 years of #iPSC discovery, our Co-Founder @MadridMarinna will represent @CellinoBio as 1 of only 2 U.S. companies invited to speak at @KeystoneSymp’s #KSiPSCs26 conference in #Kyoto, Japan. 📄 Read the full release: bit.ly/4aavayZ

🧬#Aging is inevitable, but growing older doesn’t have to come with #degenerativedisease. During #JPMWeek2026, our Co-Founder @MadridMarinna shared why “#healthcare is anti-aging.” 📄 Read @sci_steph’s full article in @TheScientistLLC: the-scientist.com/aging-research…

🌁 Reflecting on #JPMWeek and #BiotechShowcase, our Co-Founder & Chief Product Officer, @MadridMarinna, shared how autologous #iPSC-based therapies are “enabling a form of #regenerativehealth” by replacing cells and addressing #aging at its source. We’re excited to continue these conversations and share more highlights from last week!

🧬 @CellinoBio is building an automated, closed system to solve one of medicine’s toughest challenges: scaling personalized #celltherapies. Hear how from our CEO, @nabsicle, on “What’s Your Problem?” with @pushkinpods host @JacobGoldstein. 🎧 Listen now: pushkin.fm/podcasts/whats…

From bespoke stem cells to automated biology, two founders explain how personalization may finally scale in regenerative medicine. longevity.technology/news/the-futur… #longevity #regenerativemedicine #stemcells #celltherapy #personalizedmedicine #biotech #biomanufacturing #syntheticbiology

We’re excited to announce our collaboration with Polyphron to build end-to-end manufacturing for personalized #tissuetherapies, addressing the core constraint to scaling #regenmed and advancing tissue replacement. 📄 Read the full release: businesswire.com/news/home/2026…

🌉 Join us at #BiotechShowcase during #JPMWeek as @MadridMarinna joins the Transforming Aging: #Longevity & #Healthspan Therapeutics workshop as a featured speaker on Jan 12, 2026 (8:00–9:00 AM PT). 🔗 Register to attend: informaconnect.com/biotech-showca…

🚀 The @enginexyz’s #ToughTechSummit returns to #Boston this month! Our CEO @Nabsicle will speak on “Accelerating Tough Tech through AI & Automation” (Oct 10, 10:15 AM ET), sharing our #AI-driven vision for personalized medicines. 👉 engine.xyz/toughtechsummit

👏 Congratulations to our Founder & CEO, @nabsicle named a 2025 @BioSpace 40 Under 40 honoree for #innovation and #patientimpact in #biotech! See the full list ➡️ bit.ly/4o5FegH

Think of your body as the greatest artwork ever created. Each cell is a brushstroke. Today our Co-Founder & CPO @MadridMarinna is launching her Substack, starting with how iPSCs let us rewind biology’s brushstrokes!🎨 Take a peek → @biophysica/p-174851488" target="_blank" rel="nofollow noopener">substack.com/@biophysica/p-…

📢 Honored to announce that our Co-Founder & CEO, @nabsicle, will be co-chairing the @NASEM_Health’s “Developing Regenerative Medicine Therapies with #AI” workshop on Nov 18 in #DC. 👉 Join us in person or online: bit.ly/4n2GP6s

🧬How can #AI scale autologous iPSC therapies? Bar Makovoz, PhD, our Associate Director of Product Management, shares insights Oct 9 at @ISSCR’s AI & Digital Biology Symposium in #Seattle. Join us: bit.ly/3HJLPhq